Syros Pharmaceuticals Inc (SYRS)
0.2743
-0.09
(-23.78%)
USD |
NASDAQ |
Nov 14, 16:00
0.273
0.00 (0.00%)
After-Hours: 16:51
Syros Pharmaceuticals Total Liabilities (Quarterly): 96.12M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 96.12M |
| June 30, 2024 | 113.07M |
| March 31, 2024 | 119.67M |
| December 31, 2023 | 151.51M |
| September 30, 2023 | 111.49M |
| June 30, 2023 | 107.74M |
| March 31, 2023 | 98.57M |
| December 31, 2022 | 116.75M |
| September 30, 2022 | 155.55M |
| June 30, 2022 | 95.22M |
| March 31, 2022 | 89.34M |
| December 31, 2021 | 97.72M |
| September 30, 2021 | 101.98M |
| June 30, 2021 | 103.76M |
| March 31, 2021 | 110.75M |
| December 31, 2020 | 122.70M |
| September 30, 2020 | 87.40M |
| June 30, 2020 | 85.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 84.86M |
| December 31, 2019 | 70.79M |
| September 30, 2019 | 49.26M |
| June 30, 2019 | 39.91M |
| March 31, 2019 | 24.41M |
| December 31, 2018 | 28.18M |
| September 30, 2018 | 25.80M |
| June 30, 2018 | 22.67M |
| March 31, 2018 | 23.60M |
| December 31, 2017 | 13.16M |
| September 30, 2017 | 10.08M |
| June 30, 2017 | 7.95M |
| March 31, 2017 | 7.887M |
| December 31, 2016 | 10.72M |
| September 30, 2016 | 9.629M |
| June 30, 2016 | 7.552M |
| March 31, 2016 | 6.908M |
| December 31, 2015 | 9.582M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
70.79M
Minimum
Dec 2019
155.55M
Maximum
Sep 2022
106.02M
Average
102.87M
Median
Total Liabilities (Quarterly) Benchmarks
| Baxter International Inc | 18.60B |
| AbbVie Inc | 137.35B |
| Elanco Animal Health Inc | 6.76B |
| Opus Genetics Inc | 4.198M |
| Entrada Therapeutics Inc | 132.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.00M |
| Shareholders Equity (Quarterly) | -11.12M |